
Research ArticlePhase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
Keywords: TACE; transarterial chemoembolization; HCC; hepatocellular carcinoma; TTP; time to progression; BCLC; Barcelona Clinic Liver Cancer; VEGF; vascular endothelial growth factor; RECIST; Response Evaluation Criteria in Solid Tumors; CTCAE; Common Terminology